Cargando…
Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation
Transient Receptor Potential (TRP) Vanilloid 1 and Ankyrin 1 (TRPV1, TRPA1) cation channels are expressed in nociceptive primary sensory neurons, and integratively regulate nociceptor and inflammatory functions. Lipid rafts are liquid-ordered plasma membrane microdomains rich in cholesterol, sphingo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873636/ https://www.ncbi.nlm.nih.gov/pubmed/33584270 http://dx.doi.org/10.3389/fphar.2020.593319 |
_version_ | 1783649425434869760 |
---|---|
author | Horváth, Ádám Payrits, Maja Steib, Anita Kántás, Boglárka Biró-Süt, Tünde Erostyák, János Makkai, Géza Sághy, Éva Helyes, Zsuzsanna Szőke, Éva |
author_facet | Horváth, Ádám Payrits, Maja Steib, Anita Kántás, Boglárka Biró-Süt, Tünde Erostyák, János Makkai, Géza Sághy, Éva Helyes, Zsuzsanna Szőke, Éva |
author_sort | Horváth, Ádám |
collection | PubMed |
description | Transient Receptor Potential (TRP) Vanilloid 1 and Ankyrin 1 (TRPV1, TRPA1) cation channels are expressed in nociceptive primary sensory neurons, and integratively regulate nociceptor and inflammatory functions. Lipid rafts are liquid-ordered plasma membrane microdomains rich in cholesterol, sphingomyelin and gangliosides. We earlier showed that lipid raft disruption inhibits TRPV1 and TRPA1 functions in primary sensory neuronal cultures. Here we investigated the effects of sphingomyelinase (SMase) cleaving membrane sphingomyelin and myriocin (Myr) prohibiting sphingolipid synthesis in mouse pain models of different mechanisms. SMase (50 mU) or Myr (1 mM) pretreatment significantly decreased TRPV1 activation (capsaicin)-induced nocifensive eye-wiping movements by 37 and 41%, respectively. Intraplantar pretreatment by both compounds significantly diminished TRPV1 stimulation (resiniferatoxin)-evoked thermal allodynia developing mainly by peripheral sensitization. SMase (50 mU) also decreased mechanical hyperalgesia related to both peripheral and central sensitizations. SMase (50 mU) significantly reduced TRPA1 activation (formalin)-induced acute nocifensive behaviors by 64% in the second, neurogenic inflammatory phase. Myr, but not SMase altered the plasma membrane polarity related to the cholesterol composition as shown by fluorescence spectroscopy. These are the first in vivo results showing that sphingolipids play a key role in lipid raft integrity around nociceptive TRP channels, their activation and pain sensation. It is concluded that local SMase administration might open novel perspective for analgesic therapy. |
format | Online Article Text |
id | pubmed-7873636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78736362021-02-11 Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation Horváth, Ádám Payrits, Maja Steib, Anita Kántás, Boglárka Biró-Süt, Tünde Erostyák, János Makkai, Géza Sághy, Éva Helyes, Zsuzsanna Szőke, Éva Front Pharmacol Pharmacology Transient Receptor Potential (TRP) Vanilloid 1 and Ankyrin 1 (TRPV1, TRPA1) cation channels are expressed in nociceptive primary sensory neurons, and integratively regulate nociceptor and inflammatory functions. Lipid rafts are liquid-ordered plasma membrane microdomains rich in cholesterol, sphingomyelin and gangliosides. We earlier showed that lipid raft disruption inhibits TRPV1 and TRPA1 functions in primary sensory neuronal cultures. Here we investigated the effects of sphingomyelinase (SMase) cleaving membrane sphingomyelin and myriocin (Myr) prohibiting sphingolipid synthesis in mouse pain models of different mechanisms. SMase (50 mU) or Myr (1 mM) pretreatment significantly decreased TRPV1 activation (capsaicin)-induced nocifensive eye-wiping movements by 37 and 41%, respectively. Intraplantar pretreatment by both compounds significantly diminished TRPV1 stimulation (resiniferatoxin)-evoked thermal allodynia developing mainly by peripheral sensitization. SMase (50 mU) also decreased mechanical hyperalgesia related to both peripheral and central sensitizations. SMase (50 mU) significantly reduced TRPA1 activation (formalin)-induced acute nocifensive behaviors by 64% in the second, neurogenic inflammatory phase. Myr, but not SMase altered the plasma membrane polarity related to the cholesterol composition as shown by fluorescence spectroscopy. These are the first in vivo results showing that sphingolipids play a key role in lipid raft integrity around nociceptive TRP channels, their activation and pain sensation. It is concluded that local SMase administration might open novel perspective for analgesic therapy. Frontiers Media S.A. 2021-01-27 /pmc/articles/PMC7873636/ /pubmed/33584270 http://dx.doi.org/10.3389/fphar.2020.593319 Text en Copyright © 2021 Horváth, Payrits, Steib, Kántás, Biró-Süt, Erostyák, Makkai, Sághy, Helyes and Szőke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Horváth, Ádám Payrits, Maja Steib, Anita Kántás, Boglárka Biró-Süt, Tünde Erostyák, János Makkai, Géza Sághy, Éva Helyes, Zsuzsanna Szőke, Éva Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation |
title | Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation |
title_full | Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation |
title_fullStr | Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation |
title_full_unstemmed | Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation |
title_short | Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation |
title_sort | analgesic effects of lipid raft disruption by sphingomyelinase and myriocin via transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 ion channel modulation |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873636/ https://www.ncbi.nlm.nih.gov/pubmed/33584270 http://dx.doi.org/10.3389/fphar.2020.593319 |
work_keys_str_mv | AT horvathadam analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation AT payritsmaja analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation AT steibanita analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation AT kantasboglarka analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation AT birosuttunde analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation AT erostyakjanos analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation AT makkaigeza analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation AT saghyeva analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation AT helyeszsuzsanna analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation AT szokeeva analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation |